Showing results (671-680 of 895) with videos related to

Sort By:
Pageof 90
Drugs in R&D|January 8, 2016
Effects of CYP3A4 Inhibitors Ketoconazole and Verapamil and the CYP3A4 Inducer Rifampicin on the Pharmacokinetic Parameters of Fostamatinib: Results from In Vitro and Phase I Clinical StudiesPaul Martin, Michael Gillen, David Millson, et al.
Drugs in R&D|January 10, 2016
Current and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its SymptomsMark P Murphy, Emma Caraher
Drugs in R&D|January 10, 2016
Applicability of a Single Time Point Strategy for the Prediction of Area Under the Concentration Curve of Linezolid in Patients: Superiority of Ctrough- over Cmax-Derived Linear Regression ModelsNuggehally R Srinivas, Muzeeb Syed
Drugs in R&D|January 11, 2016
Effects of Fostamatinib on the Pharmacokinetics of Oral Contraceptive, Warfarin, and the Statins Rosuvastatin and Simvastatin: Results From Phase I Clinical StudiesP Martin, M Gillen, J Ritter, et al.
Drugs in R&D|December 31, 2015
Safety of Epidural Corticosteroid InjectionsIppokratis Pountos, Michalis Panteli, Gavin Walters, et al.
Drugs in R&D|March 30, 2016
Significant Pharmacokinetic Interactions Between Quinine and Ampicillin-Cloxacillin CombinationOlubunmi B Falade, Adeyinka G Falusi, Ajibola A Olaniyi, et al.
Drugs in R&D|March 19, 2016
Safety, Tolerability and Pharmacokinetics of FAAH Inhibitor V158866: A Double-Blind, Randomised, Placebo-Controlled Phase I Study in Healthy VolunteersStephen Pawsey, Mike Wood, Helen Browne, et al.
Drugs in R&D|February 26, 2016
Cytotoxicity of Oxycodone and Morphine in Human Neuroblastoma and Mouse Motoneuronal Cells: A Comparative ApproachMerja Kokki, Maija Pesonen, Piia Vehviläinen, et al.
Drugs in R&D|February 20, 2016
Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot StudyAndré Rodrigues Durães, Pollianna de Souza Roriz, Bianca de Almeida Nunes, et al.
Drugs in R&D|January 17, 2025
Characterization for the Similarity Assessment Between the Proposed Biosimilar SB17 and Ustekinumab Reference Product Using State-of-the-Art Analytical MethodsSung-Yong Yang, Changsoo Lee, Keumbi Hwang, et al.
Pageof 90